Crucially, the treatment counteracted the abnormal expression of cytokeratin-10 (CK-10), suggesting a capacity to modulate the hyperkeratinization typical of acne lesions, and significantly inhibited bacterial biofilm formation without affecting the growth of Cutibacterium acnes, thereby preserving the skin microbiome [39]. The gene discussed is KRT10; the disease is acne.